JENNIFER GAMBLE: Open Payments
NPI 1144991480 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 11 payments from 9 companies in 2025. Trend: 2023 $321 · 2024 $486 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $152 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| Exact Sciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: ZEPBOUND, AUSTEDO XR, Cologuard Collection Kit, Wegovy, AIRSUPRA, GARDASIL 9, NURTEC ODT, JARDIANCE.
Industry payments across DE — which companies pay providers there.
